2,691pGBX-5.00p (-0.19%)
RELX PLC, together with its subsidiaries, provides information-based analytics and decision tools for professional and business customers in North America, Europe, and internationally.
RELX PLC in the Industrials sector is trading at 2,691p. The stock is currently 36% below its 52-week high of 4,183p, remaining 12.7% below its 200-day moving average. Technical signals show neutral RSI of 66 and bullish MACD crossover, explaining why REL.L maintains its current current market pressure. The Whystock Score of 55/100 suggests a balanced risk-reward profile.
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
RELX PLC, together with its subsidiaries, provides information-based analytics and decision tools for professional and business customers in North America, Europe, and internationally. It operates through four segments: Risk; Scientific, Technical & ...
The Fair Value price target for RELX is now £36.42, slightly lower than £36.67, alongside a separate move that trims a sterling based target by 390 GBp while another target in the US market is raised to US$47.20 from US$46. Recent analyst commentary shows this split clearly, with more optimistic views pointing to earnings resilience and more cautious voices questioning how much upside is already captured in current expectations. As you read on, you will see how these different targets shape...
Recent share performance and business context RELX (LSE:REL) has drawn attention after a recent move in its share price, as investors weigh its information based analytics business model, segment mix, and longer term return profile across different time horizons. See our latest analysis for RELX. At a share price of £26.96, RELX has recently paired a 12.66% 1 month share price return with a weaker year to date share price return of 9.62% and a 1 year total shareholder return decline of...
LexisNexis Risk Solutions, a division of RELX, has integrated its digital health data platform with Agenium's platform. The collaboration is designed to give life insurers smoother access to electronic health records for underwriting decisions. The move expands RELX's role in health data analytics within life insurance. For investors watching RELX (LSE:REL), this development sits alongside a mixed share price picture. The stock trades at £27.06, with a 7.9% gain over the past week and 8.5%...
Watch the Fireside Below, or Click HERE: Tech Edge hosted a fireside chat on March 24 at RSA Conference 2026 in San Francisco with Garrett Gafke, Chief Operating Officer at Mitek Systems, Inc. (Nasdaq: MITK). The in-person interview was joined by Editor-in-Chief John Jannarone and they discussed the drivers behind the rise of synthetic identity […]
Watch the Fireside Below, or Click HERE: Tech Edge hosted a fireside chat on March 25 at RSA Conference 2026 in San Francisco with Lisa Kaplan, Founder and CEO at Alethea. The in-person interview was joined by Editor-in-Chief John Jannarone and they discussed why the company sets the standard for innovation in digital risk intelligence and […]